Home
App Analytics
Drug Infusion in UCI Emergency
Drug Infusion in UCI Emergency Vs. IV Medications Gahart

Drug Infusion in UCI Emergency vs IV Medications Gahart Usage & Stats

This application was made by doctors to facilitate the day-to-day of the professional who works in urgency, emergency, intensive care or with critically ill patients and need to calculate the concentration of the solutions used and infusion speed quickly. The application has a suggested standard solution based on the schemes most used in intensive care services and allows editing and saving your favorite solutions. The application also allows the creation of new solutions from the ampoules available in its service, the calculation of the dosage in mL/hour and the possibility of converting the infused speed into an infused concentration and vice versa. In addition, it is possible to view the therapeutic range individually for the patient's weight as guided by some medical bibliographies and the adjustment of this range by the user depending on the objective and clinical judgment. Thus, the application increases patient safety when prescribing these drugs reducing the risk of calculation errors by the professional. The application also has messages to warn about photosensitive solutions and medications that must be diluted in a specific medium such as physiological solution or glucose solution, thus preventing changes in their therapeutic properties. The application is available in english, portuguese and spanish.

Apple App Store
Paid
Medical

Store Rank

- -

IV Medications Gahart

Trusted for over 45 years, Intravenous Medications contains everything needed for the safe and effective administration of IV drugs. Updated annually, this comprehensive resource contains detailed monographs that include dosage, administration, contraindications, precautions, interactions, antidotes, and more. This app helps nurses, nursing students, and health professionals avoid errors by using the built-in calculator to determine precise dilution and rate of administration. Download this app to see how it will build confidence and help you provide better patient care with its intuitive, quick-access format. Features of Intravenous Medications include: • 400+ detailed generic and trade name IV drug monographs • Annual updates • New monographs featuring recently FDA approved drugs • Helpful calculator and charts for dilution and rate of administration • Black Box Warnings highlighting critical information • Blue-screened text call attention to important circumstances that may not warrant Black Box Warnings. • Life-stage dosage variances for geriatric, pediatric, infant, and neonatal patients • Updated drug interactions, precautions, alerts, and patient teaching instructions for all IV drugs • Dilution and dosage charts within monographs provide quick access to essential clinical information • Advanced Search help you find terms fast • “Favorites” for bookmarking important entries • Personalize your app with notes and highlights FREE 14-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete IV Medications mobile app free for 14 days • After 14 days, your iTunes account will be charged $49.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. • To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage. • NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period. iTunes automatic renewal feature: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current 12 month period. Your iTunes account will automatically be charged the current renewal rate ($49.99) within 24 hours prior to the end of the subscription period. This will ensure you receive all updates and continued web access for the following year. If you choose not to renew, you will be able to use the app, however will not receive updates. Authors: Shelly Rainforth Collins, PharmD, BCGP Publisher: Elsevier Powered by: Unbound Medicine Unbound Privacy Policy: www.unboundmedicine.com/privacy Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement